These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

295 related articles for article (PubMed ID: 35163538)

  • 1. C-Reactive Protein as a Biomarker for Major Depressive Disorder?
    Orsolini L; Pompili S; Tempia Valenta S; Salvi V; Volpe U
    Int J Mol Sci; 2022 Jan; 23(3):. PubMed ID: 35163538
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association between C-reactive protein (CRP) with depression symptom severity and specific depressive symptoms in major depression.
    Köhler-Forsberg O; Buttenschøn HN; Tansey KE; Maier W; Hauser J; Dernovsek MZ; Henigsberg N; Souery D; Farmer A; Rietschel M; McGuffin P; Aitchison KJ; Uher R; Mors O
    Brain Behav Immun; 2017 May; 62():344-350. PubMed ID: 28257825
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Associations of number and severity of depressive episodes with C-reactive protein and Interleukin-6.
    Jeenger J; Sharma M; Mathur DM; Amandeep
    Asian J Psychiatr; 2017 Jun; 27():71-75. PubMed ID: 28558901
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Abnormal C-reactive protein blood levels as a specific biomarker of major depression and non-remission under antidepressants in schizophrenia.
    Fond G; Micoulaud-Franchi JA; Faugere M; Boyer L; Faget-Agius C; Lançon C; Richieri R; Cermolacce M
    Prog Neuropsychopharmacol Biol Psychiatry; 2020 Mar; 97():109800. PubMed ID: 31676465
    [TBL] [Abstract][Full Text] [Related]  

  • 5. C-reactive protein: A differential biomarker for major depressive disorder and bipolar II disorder.
    Chang HH; Wang TY; Lee IH; Lee SY; Chen KC; Huang SY; Yang YK; Lu RB; Chen PS
    World J Biol Psychiatry; 2017 Feb; 18(1):63-70. PubMed ID: 26895280
    [TBL] [Abstract][Full Text] [Related]  

  • 6. C-reactive protein and cortisol in drug-naïve patients with short-illness-duration first episode major depressive disorder: possible role of cortisol immunomodulatory action at early stage of the disease.
    Cubała WJ; Landowski J
    J Affect Disord; 2014 Jan; 152-154():534-7. PubMed ID: 24161452
    [TBL] [Abstract][Full Text] [Related]  

  • 7. History of major depression is associated with neuropsychiatric symptoms but not systemic inflammation in a cross-sectional study in obese patients.
    Oriolo G; Huet L; Dexpert S; Beau C; Forestier D; Ledaguenel P; Magne E; Martin-Santos R; Capuron L
    Brain Behav Immun; 2019 Feb; 76():215-222. PubMed ID: 30476563
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The relation between depression and inflammation].
    Fisker L; Köhler-Forsberg O; Hageman I
    Ugeskr Laeger; 2018 May; 180(20):. PubMed ID: 29761778
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neutrophil-lymphocyte Ratio and C-reactive Protein Level in Patients with Major Depressive Disorder Before and After Pharmacotherapy.
    Adhikari A; Dikshit R; Karia S; Sonavane S; Shah N; De Sousa A
    East Asian Arch Psychiatry; 2018 Jun; 28(2):53-58. PubMed ID: 29921741
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sustained low-grade pro-inflammatory state in unmedicated, remitted women with major depressive disorder as evidenced by elevated serum levels of the acute phase proteins C-reactive protein and serum amyloid A.
    Kling MA; Alesci S; Csako G; Costello R; Luckenbaugh DA; Bonne O; Duncko R; Drevets WC; Manji HK; Charney DS; Gold PW; Neumeister A
    Biol Psychiatry; 2007 Aug; 62(4):309-13. PubMed ID: 17178112
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sex differences in the association of baseline c-reactive protein (CRP) and acute-phase treatment outcomes in major depressive disorder: Findings from the EMBARC study.
    Jha MK; Minhajuddin A; Chin-Fatt C; Greer TL; Carmody TJ; Trivedi MH
    J Psychiatr Res; 2019 Jun; 113():165-171. PubMed ID: 30959227
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pre-treatment peripheral biomarkers associated with treatment response in panic symptoms in patients with major depressive disorder and panic disorder: A 12-week follow-up study.
    Kim K; Jang EH; Kim AY; Fava M; Mischoulon D; Papakostas GI; Kim H; Na EJ; Yu HY; Jeon HJ
    Compr Psychiatry; 2019 Nov; 95():152140. PubMed ID: 31669792
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Magnesium, C-reactive protein, and cortisol in drug-naïve patients with short illness-duration, first episode major depressive disorder: possible immunomodulatory role for magnesium.
    Cubała WJ; Landowski J; Dziadziuszko M; Chrzanowska A; Wielgomas B
    Magnes Res; 2016 Apr; 29(4):169-174. PubMed ID: 27965189
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The association of serum C-reactive protein with the occurrence and course of postpartum depression.
    Miller ES; Hoxha D; Pinheiro E; Grobman WA; Wisner KL
    Arch Womens Ment Health; 2019 Feb; 22(1):129-132. PubMed ID: 29654412
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cumulative meta-analysis of interleukins 6 and 1β, tumour necrosis factor α and C-reactive protein in patients with major depressive disorder.
    Haapakoski R; Mathieu J; Ebmeier KP; Alenius H; Kivimäki M
    Brain Behav Immun; 2015 Oct; 49():206-15. PubMed ID: 26065825
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Major depression, C-reactive protein, and incident ischemic heart disease in healthy men and women.
    Surtees PG; Wainwright NW; Boekholdt SM; Luben RN; Wareham NJ; Khaw KT
    Psychosom Med; 2008 Oct; 70(8):850-5. PubMed ID: 18725428
    [TBL] [Abstract][Full Text] [Related]  

  • 17. C-reactive protein is elevated in atypical but not nonatypical depression: data from the National Health and Nutrition Examination survey (NHANES) 1999-2004.
    Hickman RJ; Khambaty T; Stewart JC
    J Behav Med; 2014 Aug; 37(4):621-9. PubMed ID: 23624671
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Elevated inflammatory markers in women with remitted major depressive disorder and the role of early life maltreatment.
    Dittrich K; Boedeker K; Kluczniok D; Hindi Attar C; Winter SM; Roepke S; Heim C; Herpertz SC; Bermpohl F
    Brain Behav Immun; 2021 Oct; 97():219-225. PubMed ID: 34339804
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Biological profiling of prospective antidepressant response in major depressive disorder: Associations with (neuro)inflammation, fatty acid metabolism, and amygdala-reactivity.
    Mocking RJT; Nap TS; Westerink AM; Assies J; Vaz FM; Koeter MWJ; Ruhé HG; Schene AH
    Psychoneuroendocrinology; 2017 May; 79():84-92. PubMed ID: 28262603
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inflammation as a predictive biomarker for response to omega-3 fatty acids in major depressive disorder: a proof-of-concept study.
    Rapaport MH; Nierenberg AA; Schettler PJ; Kinkead B; Cardoos A; Walker R; Mischoulon D
    Mol Psychiatry; 2016 Jan; 21(1):71-9. PubMed ID: 25802980
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.